Search Results 61-70 of 21710 for Adenocarcinoma

1. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   ... Adenocarcinoma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

2. Rectal cancer - Stages - Mayo Clinic

   Long-term oncologic outcomes of minimally invasive proctectomy for rectal adenocarcinoma. Journal of Gastrointestinal Surgery. 2018; doi:10.1007/s11605-018 ...

3. Study of Validated Biomarkers in Urine for Patients with Adenocarcinoma of the Prostate - Mayo Clinic

   Study of Validated Biomarkers in Urine for Patients with Adenocarcinoma of the Prostate · Overview · Participation eligibility · Participating Mayo Clinic ...

4. Study Of Quemliclustat And Chemotherapy Versus Placebo And Chemotherapy In Patients With Metastatic Pancreatic Ductal Adenocarcinoma - Mayo Clinic

   Study Of Quemliclustat And Chemotherapy Versus Placebo And Chemotherapy In Patients With Metastatic Pancreatic Ductal Adenocarcinoma · Overview · Participation ...

5. Assessing the performance of methylated DNA markers in blood for detection of pancreatic ductal adenocarcinoma - Mayo Clinic

   A blood test combining methylated DNA markers with carbohydrate antigen 19-9 detects pancreatic ductal adenocarcinoma with high accuracy.

6. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma ... Adenocarcinoma. Participation ...

7. Clinical trials - Oncology (Medical)

   ... Adenocarcinoma (PDAC) patients and is a reliable biomarker of response. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1 ...

8. Detection of esophageal cancer via assay of novel methylated DNA markers in plasma - Mayo Clinic

   The two main subtypes of esophageal cancer, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), are both increasing in incidence.

9. Clinical trials - Oncology (Medical)

   Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL). Rochester, Minn. This is a ...

10. A Study of the Safety and Effectiveness of TH-302 Combined with Gemcitabine and Compared with Gemcitabine Alone for Previously Untreated Patients with Pancreatic Adenocarcinoma - Mayo Clinic

    ... Adenocarcinoma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...